PCR22 Treatment Preferences Among Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma in the United States
Jun 1, 2023, 00:00 AM
10.1016/j.jval.2023.03.1802
https://www.valueinhealthjournal.com/article/S1098-3015(23)01902-2/fulltext
Section Title :
Section Order :
11130
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01902-2&doi=10.1016/j.jval.2023.03.1802